Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial
- 8 August 2017
- journal article
- research article
- Published by SAGE Publications in Restorative Neurology and Neuroscience
- Vol. 35 (4) , 385-393
Abstract
Background: Melatonin is known to be effective in curing migraine. Objective: This study aimed to investigate the therapeutic effect of melatonin versus sodium valproate in the prophylaxis of chronic migraine. Methods: This randomized, double-blind,Keywords
This publication has 22 references indexed in Scilit:
- Prophylaxis of migraine with melatoninNeurology, 2010
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task forceEuropean Journal of Neurology, 2009
- Migraine and the HypothalamusCephalalgia, 2009
- Comparison of Treatment Effect of Sodium Valprovate, Propranolol and Tricyclic Antidepressants in MigrainePakistan Journal of Biological Sciences, 2009
- Pathophysiology of MigraineNeurologic Clinics, 2009
- Hypothalamic involvement in chronic migraineJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) QuestionnaireHeadache: The Journal of Head and Face Pain, 2001
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- Urinary Melatonin Excretion Throughout the Ovarian Cycle in Menstrually Related MigraineCephalalgia, 1994
- Nocturnal Plasma Melatonin Levels in Migraine: A Preliminary ReportHeadache: The Journal of Head and Face Pain, 1989